CYP3A5 and hepatocellular carcinoma: Aflatoxin is one of the leading predisposing factors for HCC, and CYP3A5 polymorphism is linked to elevated mutagenic AFB1-exo-8,9-epoxide levels, which may control the individual risk of HCC [56].